Pre-procedure oral rabeprazole administration for the prevention of bleeding after endoscopic submucosal dissection for gastric neoplasms
Not Applicable
- Conditions
- gastric cancer
- Registration Number
- JPRN-UMIN000011487
- Lead Sponsor
- Fukushima Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Patients were excluded if they had received acid-suppressive drugs up to one week before pre-ESD endoscopy or Helicobacter pylori (Hp) eradication, or if they had a history of gastrectomy, major organ failure, or a drug allergy for PPI
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method post-ESD bleeding rate
- Secondary Outcome Measures
Name Time Method change in gastric pH